NLRP3 and inflammatory bowel disease: NLRP3-/- mice were highly susceptible to DSS-induced IBD and DSS-induced colitis-associated colorectal cancer (CAC) (37, 61), but DSS-induced IBD in WT mice was relieved via suppressing the expression of NLRP3 (38).